다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

CUR

Neuralstem (CUR)

Neuralstem Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CUR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2021/03/20	02:15	GlobeNewswire Inc.	NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COV...	NASDAQ:CUR	Neuralstem Inc
2020/09/02	21:00	PR Newswire (US)	Letter from Seneca Biopharma's Executive Chairman	NASDAQ:CUR	Neuralstem Inc
2020/05/28	00:00	PR Newswire (US)	Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering	NASDAQ:CUR	Neuralstem Inc
2019/11/05	06:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
2019/11/01	00:00	PR Newswire (US)	Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA	NASDAQ:CUR	Neuralstem Inc
2019/10/30	20:00	PR Newswire (US)	Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto...	NASDAQ:CUR	Neuralstem Inc
2019/10/30	19:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
2019/10/29	12:24	PR Newswire (US)	Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit	NASDAQ:CUR	Neuralstem Inc
2019/10/28	22:00	PR Newswire (US)	Neuralstem Becomes Seneca Biopharma	NASDAQ:CUR	Neuralstem Inc
2019/10/12	08:34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CUR	Neuralstem Inc
2019/10/12	08:32	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:CUR	Neuralstem Inc
2019/10/12	08:31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CUR	Neuralstem Inc
2019/10/12	08:28	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:CUR	Neuralstem Inc
2019/10/12	08:26	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:CUR	Neuralstem Inc
2019/10/12	08:24	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:CUR	Neuralstem Inc
2019/10/03	22:31	PR Newswire (US)	Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)	NASDAQ:CUR	Neuralstem Inc
2019/09/25	05:52	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
2019/09/24	20:30	PR Newswire (US)	Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Pat...	NASDAQ:CUR	Neuralstem Inc
2019/09/18	06:00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
2019/08/15	03:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
2019/08/14	20:32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CUR	Neuralstem Inc
2019/08/14	20:30	PR Newswire (US)	Neuralstem Reports Second Quarter 2019 Fiscal Results	NASDAQ:CUR	Neuralstem Inc
2019/08/09	22:05	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CUR	Neuralstem Inc
2019/08/07	22:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
2019/08/07	20:30	PR Newswire (US)	Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued Listing	NASDAQ:CUR	Neuralstem Inc
2019/07/31	20:30	PR Newswire (US)	Neuralstem Closes $7.5 Million Underwritten Public Offering	NASDAQ:CUR	Neuralstem Inc
2019/07/30	05:47	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:CUR	Neuralstem Inc
2019/07/26	19:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CUR	Neuralstem Inc
2019/07/26	11:40	PR Newswire (US)	Neuralstem Announces Pricing of $7.5 Million Underwritten Public Offering	NASDAQ:CUR	Neuralstem Inc
2019/07/25	19:05	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:CUR	Neuralstem Inc

검색 관련기사 보기:NASDAQ:CUR

1 2 3 4 5 6 7 8 9 10 다음 >>

Gold vs US Dollar

Financial Select Sector

Health Care Select Sector

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관